Piperidine derivative used for treating chemokine receptor 5...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/14 (2006.01) A61K 31/4545 (2006.01) A61P 31/12 (2006.01)

Patent

CA 2671473

The present invention relates to 4-{(1R,3R)-1-(3,5-difluorophenyl)-3-[4-(3-ethyl-5- isopropyl-4H- 1,2,4-triazol-4-yl)piperidin- 1 -yl]butyl} - 1 -(methylsulfonyl)piperidine formula (I) : or a pharmaceutically acceptable salt thereof, as well as to processes for preparing such a compound, to pharmaceutical compositions comprising such a compound and to the use of such a compound in the treatment of CCR5 mediated disease states.

La présente invention concerne une 4-{(1R,3R)-1-(3,5-difluorophényl)-3-[4-(3-éthyl-5-isopropyl-4H-1,2,4-triazol-4-yl)pipéridin-1-yl]butyl}-1-(méthylsulfonyl)pipéridine (I) : ou l'un de ses sels acceptables d'un point de vue pharmaceutique, ainsi que des procédés de préparation d'un tel composé, des compositions pharmaceutiques comprenant un tel composé et l'utilisation d'un tel composé dans le traitement d'états pathologiques médiés par le CCR5.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Piperidine derivative used for treating chemokine receptor 5... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidine derivative used for treating chemokine receptor 5..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine derivative used for treating chemokine receptor 5... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1533156

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.